| Detected | Trial | Change |
|---|---|---|
| 2026-08-13 | NCT05272709 TT-702 in Patients With Advanced Solid Tumours. |
Primary endpoint(s) modified |
| 2026-08-13 | NCT05272709 TT-702 in Patients With Advanced Solid Tumours. |
Enrollment reduced: 188 -> 60 participants |
| 2026-08-13 | NCT05272709 TT-702 in Patients With Advanced Solid Tumours. |
Trial arms changed: 6 -> 4 |
| 2026-08-13 | NCT05272709 TT-702 in Patients With Advanced Solid Tumours. |
date change Primary completion pushed: 2027-06 -> 2028-04 |
| 2026-08-13 | NCT05272709 TT-702 in Patients With Advanced Solid Tumours. |
date change Completion pushed: 2027-06 -> 2028-04 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2/3 | |||
| NCT05768178 | DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult… | Haematological Malignancy | Recruiting |
| NCT05770037 | DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult… | Haematological Malignancy | Recruiting |
| NCT05770102 | DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young… | Malignancy | Recruiting |
| NCT05770544 | DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young… | Haematological Malignancy | Recruiting |
| NCT06988475 | DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring… | Solid Tumour | Recruiting |
| NCT05786716 | DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult… | Haematological Malignancy | Recruiting |
| NCT05722886 | DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare… | Haematological Malignancy | Recruiting |
| NCT07440290 | DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult… | Haematological Malignancy | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT05944237 | HTL0039732 in Participants With Advanced Solid Tumours | Neoplasms | Recruiting |
| NCT06045910 | A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies | Lymphoma, Non-Hodgkin | Recruiting |
| NCT06380816 | A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer | Advanced Solid Tumours | Recruiting |
| NCT05272709 | TT-702 in Patients With Advanced Solid Tumours. | Advanced Solid Tumors | Recruiting |
| NCT05057013 | A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours | Bladder Cancer | Active, Not Recruiting |